NIHR Manchester Clinical Research Facility (CRF) shared a post on LinkedIn:
“We are delighted to announce Professor Fiona Thistlethwaite, Medical Oncology Consultant at The Christie NHS Foundation Trust, Director of the Innovate Manchester Advanced Therapy Centre Hub, and Honorary Professor at The University of Manchester, has been appointed as our new Co-Director.
Speaking about her appointment, Prof Thistlethwaite said:
‘I am honoured to be appointed as the new Co-Director of the NIHR Manchester CRF. As a clinician, my focus is always on patients, making sure they feel supported and well cared for while taking part in cutting-edge trials.’
Her research interests include how the immune system can be harnessed against cancer, in particular personalised immune cell treatments, combination immunotherapies, and immune biomarkers which can demonstrate how the immune system is responding to cancer and treatment.
Read the full announcement.”
Jonathan Lim, Co-Lead of The Manchester Immuno-Oncology Network (MION) and Lead of The Christie International Fellowship Program for Medical Oncology at The Christie NHS Foundation Trust, shared this post, adding:
“Excited that my colleague Professor Fiona Thistlethwaite has now been appointed as Co-Director of the NIHR Manchester Clinical Research Facility (CRF).
The Manchester CRF is the largest and most comprehensive NIHR-funded CRF in the UK, enabling cutting-edge clinical and experimental medicine research across a truly diverse range of therapeutic areas and patient populations – with 6 dedicated sites across Greater Manchester (including adult and paediatric services).
Looking forward to continuing to work together, so that the patients we serve can gain access to the very latest therapies and clinical studies sooner.”
You can read more posts featuring Fiona Thistlethwaite on OncoDaily.